课题基金 / 基金详情

Transgenic Mice- Recomb., Fate-Mapping,and Ca2+signaling

Transgenic Mice- Recomb., Fate-Mapping,and Ca2+signaling
转基因小鼠 - 重组、命运图谱和 Ca2 信号传导
批准号:
7194221
负责人:
Michael I. Kotlikoff
金额:
$35.57万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-03-15 至 2009-02-28

项目摘要

项目成果

Michael I. Kotlikoff的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):本提案的目的是开发、验证和利用新的转基因小鼠模型,用于研究泌尿生殖道器官神经肌肉调节的细胞和分子细节。GU器官复杂的多细胞性质是理解对GU器官生理学、病理生理学和转化至关重要的细胞相互作用的重要障碍。在小鼠中的功能获得和功能丧失转基因已经成为确定哺乳动物中单个基因的体内功能的唯一最具信息性的过程,并且在接下来的二十年中,生物学的主要努力之一将是通过选择性改变小鼠基因组来对哺乳动物基因组进行功能注释。尽管越来越多地使用这些方法来探测细胞和器官功能,并且其中重组酶识别序列已被插入特定基因以使基因可以选择性失活的小鼠的可用性越来越高,但这些方法中很少有被设计用于靶向GU细胞。本PAR提案旨在应用转基因和重组蛋白工程的方法,为GU系统的细胞研究提供工具,并使用这些小鼠来检查GU功能的各个方面。将产生单独的转基因系,其中特定的细胞谱系表达:1)配体激活的Cre重组酶转基因(Cre-ER(T2)),其中Cre重组酶处于细胞特异性和时间控制下,用于条件诱变和Ca 2+敏感性荧光研究; 2)由增强型绿色荧光蛋白(eGFP)和Cre重组酶组成的双顺反子构建体,用于条件诱变、命运作图,和用于单细胞或基因表达研究的细胞分选;和3)用于细胞功能和信号传导的谱系特异性研究的基于GFP的Ca 2+敏感性荧光蛋白(G-CaMPS 1.6x和C-CaMPS 1.3)。将对所有小鼠品系进行表征,并提供给科学界,以加速条件诱变、命运作图和体内成像技术在GU道细胞研究中的应用。我们将使用小鼠来解决与神经肌肉传递和泌尿生殖道中卡哈尔间质细胞(ICC)的发育和功能有关的重要问题。
英文摘要
DESCRIPTION (provided by applicant): The aim of this proposal is to develop, validate, and utilize new transgenic mouse models for the study of the cellular and molecular details of neuromuscular regulation of organs of the genitourinary tract. The complex, multicellular nature of GU organs is a significant barrier to the understanding of the cellular interactions that are critical to GU organ physiology, pathophysiology, and transformation. Gain-of-function and loss-of-function transgenesis in the mouse has emerged as perhaps the single most informative process in determining the in vivo function of individual genes in mammals, and over the next two decades one of the major efforts of biology will be the functional annotation of the mammalian genome through selective alterations of the mouse genome. Despite the increasing use of these methods to probe cellular and organ function, and the increasing availability of mice in which recombinase recognition sequences have been inserted for specific genes so that the genes can be selectively inactivated, few of these approaches have been designed to target cells of the GU. This PAR proposal seeks to apply methods of transgenesis and recombinant protein engineering to provide tools for the study of cells of the GU system, and to use these mice to examine aspects of GU function. Separate transgenic lines will be created in which specific cellular lineages express: 1) a ligand -activated Cre recombinase transgene (Cre-ER (T2)) in which Cre recombinase is under cell specific and temporal control for conditional mutagenesis and Ca2+ -sensitive fluorescence studies; 2) a bicistronic construct consisting of enhanced Green Fluorescent Protein (eGFP) and Cre recombinase for conditional mutagenesis, fate mapping, and cell sorting for single cell or gene expression studies; and 3) GFP - based Ca2+ -sensitive fluorescent proteins (G-CaMPS1.6x and C-CaMPS1.3) for lineage specific studies of cell function and signaling. All lines of mice will be characterized and made available to the scientific community to accelerate the use of conditional mutagenesis, fate mapping, and in-vivo imaging techniques in the study of cells of the GU tract. We will use the mice to address important questions relating to neuromuscular transmission and the development and function of Interstitial Cells of Cajal (ICC) in the urogenital tract.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vascular Precursors and Cell-Cell Signaling in Heart Vasculogenesis
  • 批准号:
    9249631
  • 项目类别:
  • 资助金额:
    $38.75万
  • 财政年份:
    2015
  • 负责人:
    Michael I. Kotlikoff
  • 依托单位:
Vascular Precursors and Cell-Cell Signaling in Heart Vasculogenesis
  • 批准号:
    8864615
  • 项目类别:
  • 资助金额:
    $38.78万
  • 财政年份:
    2015
  • 负责人:
    Michael I. Kotlikoff
  • 依托单位:
Genetic Resource for Optical Signaling
  • 批准号:
    8898204
  • 项目类别:
  • 资助金额:
    $64.34万
  • 财政年份:
    2014
  • 负责人:
    Michael I. Kotlikoff
  • 依托单位:
Genetic Resource for Optical Signaling
  • 批准号:
    9056610
  • 项目类别:
  • 资助金额:
    $64.34万
  • 财政年份:
    2014
  • 负责人:
    Michael I. Kotlikoff
  • 依托单位:
海外基金